CD4 and melanoma: In a B16 melanoma model, LOFU treatment, compared to no treatment, led to a decreased transcriptional expression of multiple anergy-associated genes, including three E3 ubiquitin ligase genes named GRAIL, Cbl-b, and Itch within CD4+ T-cells isolated from tumor-draining lymph nodes [157].